轩竹生物-B(02575.HK)：建议实施H股全流通

Core Viewpoint - The company, Xuan Zhu Biological-B (02575.HK), announced the implementation of a full circulation of H-shares, converting approximately 357 million unlisted shares held by six shareholders into H-shares, which represents about 68.9733% of the total issued shares as of the announcement date [1] Group 1 - The board of directors approved the proposal for H-share full circulation [1] - The conversion involves approximately 357 million shares [1] - The converted shares account for about 68.9733% of the total issued shares [1]